Bridgeway Capital Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-75,000
| Closed | -$125K | – | 1178 |
|
|
2024
Q4 | $125K | Buy |
+75,000
| New | +$125K | ﹤0.01% | 1084 |
|
|
2024
Q2 | – | Sell |
-20,000
| Closed | -$223K | – | 1272 |
|
|
2024
Q1 | $223K | Sell |
20,000
-13,500
| -40% | -$151K | ﹤0.01% | 1088 |
|
|
2023
Q4 | $499K | Sell |
33,500
-15,000
| -31% | -$223K | 0.01% | 945 |
|
|
2023
Q3 | $233K | Hold |
48,500
| – | – | 0.01% | 1070 |
|
|
2023
Q2 | $364K | Buy |
+48,500
| New | +$364K | 0.01% | 997 |
|